Genotype/allele TID Onset age ≤14 Control Age at onset ≤ 14Vs. Controls TIDOnset age >14   Age at onset > 14Vs. Controls
LMP2 exon3 N=99 (%) N=752(%) p  Value Odds ratio 95% CI N=117(%)  p Value Oddsratio 95% Cl
GG 74
-74.75
480 (63.82) 0.03 1.67 1.02-2.82 83
-70.94
0.13 1.38 0.89-2.19
GA 23
-23.2
241 (32.05) 0.07 0.64 0.37-1.06 31
-26.49
0.23 0.76 0.47-1.2
AA 2
-2.02
31
-4.12
0.24* 0.58** 0.23-1.48 3
-2.56
0.3* 0.7** 0.31-1.54
G 171
-86.4
1201 (79.85) 0.029 1.598 1.04-2.54 197
-84.19
0.12 1.34 0.92-2.0
A 27
-13.6
303 (20.14) 0.029 0.625 0.39-0.96 37
-15.81
0.12 0.74 0.49-1.08
LMP7
exon 2
N=97 N=742       N=115      
CC 75
-77.32
516 (69.54) 0.11 1.49 0.89-2.59 88
-76.52
0.12 1.43 0.89-2.35
AC 21
-21.65
191 (25.74) 0.38 0.79 0.45-1.35 24
-20.87
0.26 0.76 0.45-1.25
AA 1
-1.03
35 (4.72) 0.06* 0.31** 0.09-0.99 3
-2.61
0.22* 0.62** 0.28-1.36
C 171
-88.14
1223 (82.41) 0.045 1.58 0.99-2.62 200
-86.96
0.087 1.42 0.94-2.21
A 23
-11.86
261 (17.58) 0.045 0.63 0.38-1.0 30
-13.04
0. 087 0.7 0.45-1.06
LMP7
Intron 6
N=99 N=738       N=118      
GG 45
-45.45
245
-33.2
0.016 1.67 1.07-2.62 42
-35.59
0.61 1.11 0.72-1.69
GT 40
-40.4
332 (44.99) 0.39 0.82 0.53-1.29 57
-48.3
0.5 1.14 0.76-1.72
TT 14
-14.14
161 (21.81) 0.08 0.59 0.3-1.08 19
-16.1
0.16 0.69 0.38-1.17
G 130
-65.66
822
-55.7
0.007 1.52 1.1-2.11 141
-59.75
0.22 1.19 0.89-1.59
T 68
-34.34
654
-44.3
0.007 0.66 0.47-0.9 94 0.22
-40.25
0.84 0.62-1.12
Haplotypes LMP2 exon 3,LMP7 exon 2, LMP7 intron 6@$
  2N=174 2N=1476 p  Value Odds ratio 95% CI N=210 p  Value Odds ratio 95% CI
GCG 119
-68.4
584 (39.6) 4.5x10-11* 3.05 2.16-4.29 122
-58
2x10-5* 1.89 1.41-2.54
ACT 20
-11.5
80 (5.42) 0.003* 2.14 1.28-3.6 34
-16.2
5.14x10-8* 3.15 2.05-4.86
GCT 16
-9.2
387 (26.22) 1.96x10-12* 0.32 0.23-0.44 25
-12
6.85x10-7* 0.35 0.23-0.54
ACG 0
0
164 (11.11) 2.47x10-13* 0.02** 0.003-0.16 0
0
1.32x10-7* 0.02** 0.002-0.14
Table 4: LMP2 and LMP7 SNPs and haplotypes in male Type 1 diabetes patients compared with male healthy controls.